Pediatric Gastroenterologists' Practice Styles and Compliance With European/North American Helicobacter pylori

Ashwin Agrawal1,2, Anupama Chawla3, Héctor E Alcalá4

  • 1Pediatric Gastroenterology, RWJBarnabas Health, Long Branch, USA.

Cureus
|January 21, 2026
PubMed

Insights

Pediatric gastroenterologists show mixed adherence to 2016 Helicobacter pylori (H. pylori) guidelines, with notable gaps in non-invasive testing and treatment strategies. Further education is needed, especially with updated 2024 guidelines available.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Adherence to established guidelines is crucial for effective pediatric Helicobacter pylori (H. pylori) management.
  • Previous guidelines, such as the 2016 ESPGHAN/NASPGHAN update, provide a framework for diagnosis and treatment.
  • Variations in clinical practice may impact patient outcomes and antimicrobial resistance.

Purpose of the Study:

  • To assess pediatric gastroenterologists' adherence to the 2016 European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) guidelines for H. pylori in children.
  • To identify areas of consistent application and areas needing improvement in H. pylori diagnosis and treatment protocols.
  • To inform future educational initiatives and guideline updates.

Main Methods:

  • A survey was distributed to pediatric gastroenterologists via a professional listserv.
  • The survey assessed knowledge and practices regarding H. pylori diagnosis, workup, and treatment.
  • Data were collected from April 13, 2022, to May 12, 2022, with 302 respondents from 25 countries.

Main Results:

  • The stool antigen test and upper endoscopy were the most common diagnostic methods.
  • A significant proportion of providers (40.72%) rarely or never treated H. pylori based on positive non-invasive tests.
  • Adherence was noted in waiting periods before testing and in eradication testing, but less so in non-invasive diagnosis, treatment based on non-invasive results, endoscopy use, susceptibility testing, and antibiotic choices.

Conclusions:

  • Pediatric gastroenterologists demonstrate adherence to specific aspects of the 2016 H. pylori guidelines, particularly regarding pre-testing intervals.
  • Significant deviations were observed in diagnostic approaches (favoring non-invasive tests over endoscopy), treatment decisions based on non-invasive results, and the utilization of culture and susceptibility testing.
  • There is a clear need for enhanced education on H. pylori management for pediatric gastroenterologists, particularly in light of the recently released 2024 guidelines.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...